Question to the Department of Health and Social Care:

To ask Her Majesty's Government what plans they have to stipulate as a condition of COVID-19 UK public funding that any vaccine or medical product developed is licensed according to the principles of socially responsible licensing which includes, but is not limited to, preventing exclusive licensing.

The Government is giving careful consideration to the conditions attached to COVID-19 public funding. The National Institute for Health Research is a signatory of the data sharing concordat and are working closely with research institutions to share the results of COVID-19 funded research in line with these principles. In addition, the United Kingdom has committed over £300 million to global efforts on vaccines, diagnostics and medicines, through the Coalition for Epidemic Preparedness Innovations, the Foundation for Innovative New Diagnostics, the Wellcome Trust Therapeutics Accelerator and other platforms.